Differential diagnosis between patients with probable Alzheimer’s disease, Parkinson’s disease dementia, or dementia with Lewy bodies and frontotemporal dementia, behavioral variant, using quantitative electroencephalographic features by Heinrich Garn et al.
NEUROLOGY AND PRECLINICAL NEUROLOGICAL STUDIES - ORIGINAL ARTICLE
Differential diagnosis between patients with probable Alzheimer’s
disease, Parkinson’s disease dementia, or dementia with Lewy
bodies and frontotemporal dementia, behavioral variant, using
quantitative electroencephalographic features
Heinrich Garn1 • Carmina Coronel1 • Markus Waser1 • Georg Caravias2 •
Gerhard Ransmayr3
Received: 3 November 2016 / Accepted: 14 February 2017
 The Author(s) 2017. This article is published with open access at Springerlink.com
Abstract The objective of this work was to develop and
evaluate a classifier for differentiating probable Alzhei-
mer’s disease (AD) from Parkinson’s disease dementia
(PDD) or dementia with Lewy bodies (DLB) and from
frontotemporal dementia, behavioral variant (bvFTD)
based on quantitative electroencephalography (QEEG). We
compared 25 QEEG features in 61 dementia patients (20
patients with probable AD, 20 patients with PDD or
probable DLB (DLBPD), and 21 patients with bvFTD).
Support vector machine classifiers were trained to distin-
guish among the three groups. Out of the 25 features, 23
turned out to be significantly different between AD and
DLBPD, 17 for AD versus bvFTD, and 12 for bvFTD
versus DLBPD. Using leave-one-out cross validation, the
classification achieved an accuracy, sensitivity, and speci-
ficity of 100% using only the QEEG features Granger
causality and the ratio of theta and beta1 band powers.
These results indicate that classifiers trained with selected
QEEG features can provide a valuable input in distin-
guishing among AD, DLB or PDD, and bvFTD patients. In
this study with 61 patients, no misclassifications occurred.
Therefore, further studies should investigate the potential
of this method to be applied not only on group level but
also in diagnostic support for individual subjects.
Keywords Alzheimer’s disease  Dementia with Lewy
bodies  Frontotemporal dementia  Parkinson’s disease
dementia  Quantitative electroencephalogram
Introduction
Alzheimer´s disease (AD), the most frequent degenerative
dementia, is clinically characterized by progressive
impairment of episodic memory and other cognitive
domains (e.g., language, reasoning, visuospatial functions,
managing complex tasks, daily routine, and behavioral
abnormalities). AD is typically associated with the dys-
function of the temporal, parietal, and also occipital lobes
and atrophy of the hippocampus.
In Parkinson’s disease, up to 85% of patients develop
Parkinson’s disease dementia (PDD) in the course of their
motor disease (Dubois et al. 2007; Emre et al. 2007). PDD
often appears in combination with psychotic features,
depression, and marked impairment of axial motor func-
tions. However, some patients also develop dementia,
psychotic episodes, fluctuations of vigilance and cognition,
and parkinsonian motor features combined with autonomic
symptoms and REM sleep behavior disorder within a short
period of time, or dementia may precede levodopa-re-
sponsive parkinsonian motor symptoms. The term demen-
tia with Lewy bodies (DLB) has been coined (McKeith
et al. 2005) to describe this condition; however, clinical
similarities of PDD and DLB have been emphasized for
clinical practice (McKeith et al. McKeith et al. 2005).
Frontotemporal dementia (FTD) is caused by fron-
totemporal lobar degeneration. The differential diagnosis
of FTD may be difficult due to the heterogeneity of partly
overlapping the symptoms. Three groups are distinguished
(motor, language, and behavior), where the behavioral
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variant FTD (bvFTD) is characterized by changes in social
behavior and conduct, with loss of social awareness, apa-
thy, hyperorality and dietary changes, and poor impulse
control combined with deficits in executive tasks (Ras-
covsky et al. 2011). FTD accounts for up to 20% of young-
onset dementia cases. Diagnostic criteria exist (Rascovsky
and Grossmann 2013), but the disease remains poorly
recognized yet.
Clinicopathological studies suggest differences, but also
a continuum between and neuropathological overlaps of
the three disorders; however, specific diagnosis is war-
ranted for prognosis and treatment. Difficulties of differ-
ential diagnosis have been discussed (Bonanni et al. 2008;
Li et al. 2016), concluding that the clinical symptoms can
vary largely in that they may variably appear during the
course of the disease. There are no specific biological
markers for these diseases. Differential diagnosis may be
complex and expensive [magnetic resonance (MR) imag-
ing (MRI), dopamine transporter (FP-Cit) single photon
emission computed tomography (SPECT), FDG or amyloid
positron emission tomography (PET), cerebrospinal fluid
examination, repeated clinical and neuropsychological
evaluation, and genetic testing]. Moreover, positivity in
amyloid PET, the most recent advanced diagnostic tool, is
not AD specific and may also be found in DLB and FTD
(Ossenkoppele et al. 2015).
Consequently, there is an ongoing need for diagnostic
improvement. Electroencephalography (EEG) is cost-ef-
fective and available as the standard equipment in most
primary, secondary, and tertiary neurological and psychi-
atric referral centers and in neurological practice. Signifi-
cant correlations between various features of quantitative
EEG (QEEG) and the severity of AD have already been
demonstrated (Garn et al. 2014, 2015). A slowing of the
frequency spectrum to variable extent is a characteristic
feature of degenerative dementias, such as AD or DLB (Li
et al. 2016; Jeong 2004; Caso et al. 2012; Lindau et al.
2003). We hypothesized that, based on the previous find-
ings, frequency spectrum analysis together with more
complex parameters and statistical evaluation of QEEG
could be applied in the differential diagnosis of AD, DLB,
PDD, and bvFTD.
Only one study has investigated the possibility of dif-
ferential diagnosis between three different forms of
dementia by QEEG so far. Snaedal et al. (2012) used a
database of EEGs from seven different groups of subjects
with cognitive impairment and dementia. A classifier was
created for each possible pair of groups using statistical
pattern recognition. Accuracies of 91% (DLBPD-AD),
93% (DLBPD-FTD), and 88% (AD-FTD) were achieved
for classifications between groups.
Differentiation between AD and PDD or probable DLB
(DLBPD) was reported in (Bonanni et al. 2008; Fonseca
et al. 2013; Babiloni et al. 2011; Kai et al. 2005), but no
quantitative classification results were given. Andersson
et al (2008) evaluated EEG variability in dementia with
DLB and AD. Their features could distinguish DLB
patients from AD patients and controls with areas under the
ROC curves ranging between 0.75 and 0.80 and 0.91 and
0.97, respectively. For the differentiation between AD and
FTD, three studies can be found: Caso et al. (2012) used a
single subject analysis employing 12 spectral parameters
and achieved 48.72% sensitivity and 85% specificity.
Lindau et al. (2003) performed a logistic regression model.
A classification accuracy of 93.3% was achieved using d
and h activities, visuospatial ability, and episodic memory.
Nishida et al. (2011) found significant differences in the
relative global field power in the frequency band
12.5–18 Hz but did not give quantitative results.
The purpose of our study was to identify and evaluate
QEEG features that would help distinguishing patients with
AD, DLBPD, and bvFTD. These features were derived
from multi-channel EEG recordings made in resting state
in both time and frequency domains. The goal was to
generate quantitative, statistically significant criteria that
could be applied to patients in routine assessments in the
future. The method addresses subjects with clear cognitive
deficiencies, evident from clinical appearance, and neu-
ropsychological test scores. Consequently, the study
included no healthy controls.
Methods
Subjects
Patients were recruited at the Department of Neurology 2
of the Kepler University Hospital Linz. All subjects had a
history and presented evidence of progressive cognitive
decline from previous levels of performance interfering
with abilities to function in usual activities, reported by
themselves or by external informants, mostly spouses, and
assessed clinically and neuropsychologically. Routine
blood laboratory parameters, including serum vitamin B12
and folate serum levels, thyroid gland parameters, HIV,
and syphilis serology, were assessed to rule out unknown
metabolic and infectious diseases. The Mini Mental State
Examination (MMSE, Folstein et al. 1975), the CERAD-
plus neuropsychological battery (Schmid et al. 2014), the
Clock Drawing Test (Sunderland et al. 1989), and the
Frontal Assessment Battery (Dubois et al. 2000) were used
for cognitive testing. Psychiatric disorders, substance
abuse, medication, or other hypothesized or proven diag-
noses that could otherwise explain the cognitive decline
were ruled out as well as delirium at the time of diagnosis,
neuropsychological testing, and EEG registration. All
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patients with probable Alzheimer dementia (AD) and
frontotemporal dementia, behavioral variant (FTDbv,
clinical criteria, and diagnosis, see in the following), had a
1.5 or 3 Tesla MRI of the brain (T1, T2, FLAIR, DTI, and
T2* sequences). Patients with Parkinson’s disease demen-
tia (PDD) and dementia with Lewy Bodies (DLB) had
either cerebral MRI (1.5 or 3 Tesla, N = 12) or CT
(N = 8).
Patients with probable AD (N = 20) and FTDbv
(N = 21) participated in prospective longitudinal studies of
the Austrian Alzheimer Society (PRODEM) and of the
Kepler University Hospital Linz (FTLA Study), respec-
tively, which had been reviewed by the local ethical
committee (Ethikkommission des Landes Obero¨sterreich,
approval number 254). Patients and informants, mostly
family members, were included in the study after written
informed consent. Patients participating at the PRODEM
and FTLA studies were neuropsychologically tested but
also evaluated for neuropsychiatric and behavioral symp-
toms using the neuropsychiatric Inventory (NPI, Cum-
mings 1994), activities of daily living, and caregiving.
Patients in these studies were followed at 6-months to
1-year intervals for a minimum of 2 years unless study was
prematurely terminated because of patient needs for 24-h
homecare or institutionalization, withdrawal of consent or
death. Follow-up visits included neuropsychological test-
ing, neuropsychiatric evaluations, and MRI. In all included
patients, the initial diagnoses were confirmed in the follow-
up visits.
Patients with probable AD (McKhann et al. 1984) suf-
fered from progressive memory impairment as presenting
symptom which prevailed over other neuropsychological
deficits in follow-up visits, confirmed by neuropsycholog-
ical testing (subtests learning and retention of a word list
and recall of geometric figures of the CERADplus neu-
ropsychological battery). Behavioral and neuropsychiatric
symptoms, documented by informants using the neu-
ropsychiatric inventory (Cummings 1994), or language
impairment was not reported or insignificant. None of the
AD patients had a history of fluctuations of cognition or
alertness or parkinsonian motor syndrome. Cerebral MRI
revealed bilateral atrophies, mainly of the medial temporal
lobes and the temporoparietal neocortex, in 3 of 20
patients, albeit to a minor degree, also of the frontal cortex.
Patients with probable FTDbv (Raskovsky et al. Ras-
covsky et al. 2011) presented with typical progressive
behavioral changes and loss of insight confirmed by
informants using the NPI (Cummings 1994) and the Frontal
Behavioral Inventory (Kertesz et al. 2000), and verified by
clinical examination, without language impairment, sig-
nificant extrapyramidal motor symptoms or psychotic epi-
sodes. They exhibited deficits in frontal-executive tasks,
had unremarkable visuospatial abilities, relative sparing of
short-term memory functions (CERADplus, Schmid et al.
2014, Frontal Assessment Battery, Dubois et al. 2000,
Clock Drawing Test, Sunderland et al. 1989, and Stroop
Word Colour Test, Stroop 1935). MRI imaging and FDG-
PET (in 9 of 21 patients) revealed bilateral frontal and/or
temporal lobe atrophies or hypometabolism, respectively,
and also medial temporal atrophies.
Patients with Parkinson’s disease dementia (PDD) and
Dementia with Lewy Bodies (DLB, N = 20) fulfilled the
clinical criteria of probable PPD (Emre et al. 2007; Dubois
et al. 2007) and probable DLB McKeith et al. 2005),
respectively. All patients had a levodopa-responsive
Parkinson motor syndrome (Queen’s Square Brain Bank
Criteria for PD, and Hughes et al. 1992) and dementia,
based on history and clinical and neuropsychological
evaluation according to the literature (Dubois et al. 2007;
CERADplus, MMSE, Clock Drawing Test).
Demographic, clinical, neuropsychological, and neu-
ropsychiatric data and MRI ratings of subcortical deep
white matter lesions (using axial FLAIR images, Fazekas
et al. 1993) and medial temporal lobe atrophy (Scheltens
et al. 1992) are summarized in Table 1.
EEG data acquisition
During EEG recording, patients were awake, and delirium,
a complication of dementia, was excluded. The EEG
recordings of the AD patients were made using an a-EEG
and Neurospeed software (Alpha Trace, Austria). Record-
ings of the DLBPD and bvFTD patients were made using a
Sienna digital EEG (EMS Biomedical, Austria). The EEG
amplifiers were automatically calibrated before each
recording. Nineteen silver chloride electrodes were placed
according to the international 10–20 system. Connected
mastoids were used as a reference, and the ground elec-
trode was located in mid-frontopolar position. Horizontal
and vertical electro-oculograms (EOG) were recorded from
electrodes above and below the left eye and at the outer
corners of both eyes. The electrocardiogram (ECG) was
acquired using a wrist clip electrode. The signals were
amplified, bandpass (0.3–70 Hz) and notch (50 Hz) fil-
tered, and digitized at 256 Hz with a resolution of 16 bits.
Impedances were kept below 10 kX. The recordings were
made in a quiet room, with patients in a sitting or lying
position. They were awake with eyes closed. Patients were
instructed to avoid movements of the eyes, body, or facial
musculature, all monitored by clinicians.
EEG pre-processing
Before computing quantitative features, the following pre-
processing steps were performed. (1) The first 20 s of
continuous artifact-free recording were selected using
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visual inspection by an experienced expert and confirmed
by a second expert. Consequently, sections with artifacts
caused by poor electrode contacts or patient movement/
talking that appeared as excessive voltages were excluded
from further assessment. (2) Artifact produced by eye
movements and blinks was eliminated by linear regression
using the horizontal and vertical EOG signals. (3) Inter-
ference caused by the electric field of the heartbeat was
picked up by the EEG leads and detected by the high-
impedance EEG amplifier. This form of interference was
corrected for using a modified Pan-Tompkins algorithm
and linear regression (Waser and Garn 2013). (4) A 2-Hz
digital high-pass filter with finite impulse response was
used to eliminate fluctuations of the measured voltage
caused by sweating. (5) Finally, a sliding window was
moved automatically over the artifact-free, interference-
corrected sections of the EEG to determine a series of 4-s
epochs with an overlap of 2 s. These epochs were used to
compute the QEEG features.
QEEG features
Twenty-five QEEG features were applied in this study:
relative band powers, spectral ratios, center frequency,
auto-mutual information, cross-mutual information,
coherences, phase coherences, partial coherences, Granger
causality (GC), and conditional GC.
Frequency (spectral) measures: Frequency measures
seemed relevant for this study because shifts in relative band
power have been observed with many neurodegenerative
disorders, particularly with AD. This phenomenon has fre-
quently been described as the ‘‘slowing’’ of the EEG (Jeong
2004).Wecomputed relative bandpowers in the d (2–4 Hz),h
(4–8 Hz), a (8–13 Hz), and b1 (13–20 Hz) frequency bands
for each of the selected epochs using an indirect spectral
estimator (Waser et al. 2016). Values for each frequency band
were expressed as a percentage of the power in the total
2–20 Hz range. Spectral ratios are the ratios of low-frequency
band power over high-frequency band power: R1 = h/
(a?b1); R2 = (d ? h)/(a ? b1); R3 = h/a; R4 = h/b1.
Center frequency was computed as the center of gravity of the
2–20 Hzspectrum. In addition, relativeglobalfieldpowerwas
determined for each of the four frequency bands. Relative
global field power is the ratio of the absolute power of a fre-
quencyband fromall electrodes over the absolute power of the
total frequency band (Nishida et al. 2011).
Synchrony measures: The term synchrony refers to the
degree of simultaneousness of the brain waves measured at
different locations over the cortex. Changes in synchrony
have been reported to be associated with functional dis-
connections among cortical areas, which might be caused
by the death of cortical neurons, axonal pathology, or
cholinergic deficits. A decrease in the coherence of fast
EEG rhythms has been described as the hallmark of EEG
changes in AD (Jeong 2004). Coherence between two
channels describes the degree of association of the fre-
quency spectrum between two referential or bipolar signals
(Rosenberg et al. 1989), which can be applied to both the
signals’ amplitude and phase. Partial coherence measures
only direct spectral dependencies between the two signals.
Amplitude and phase coherence as well as partial coher-
ence were computed in the four frequency bands of d, h, a,
and b1 specified above. GC (Granger 1969) describes
whether the time course of the EEG in channel X can help
to predict the future values of the EEG signal in channel Y.
Conditional GC measures analogously only direct syn-
chrony between channel X and channel Y (Flamm et al.
2012). GC and conditional GC were computed in the fre-
quency range of 2–20 Hz and in both directions (e.g., F4/
P4 and P4/F4).
Table 1 Demographic, clinical, neuropsychological and neuropsychiatric data, MRI ratings of subcortical deep white matter lesions and medial
temporal lobe atrophy
AD (N = 20) FTDbv (N = 21) PDD/DLB (N = 20)
Mean ± SD Median Mean ± SD Median Mean ± SD Median
Age 76.9 ± 6.7 77 75.8 ± 5.7 77 74.8 ± 8.5 77
Sex 11 m, 9f 10 m, 11f 7 m, 13f
Disease duration 35.6 ± 21.3 months 36 44.3 ± 43.9 months 36 9.7 ± 7.9 years 8 years
MMSE 24 ± 4.1 23.5 23.3 ± 5.1 25 21.8 ± 5.3 22.5
FAB sum score 12.3 ± 4.3 14
NPI Sum Score 4.7 ± 6.6 2 48.1 ± 30.1 40
Fazekas Score 0.95 ± 0.88 1 1.23 ± 0.88 1 1.45 ± 1.0 (MRI N = 12, CT N = 8) 1
Scheltens Score 3.29 ± 0.75 3.5
Hoehn und Yahr Score 3.4 ± 0.5 3.5
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Measures of information theory: information processing
in the brain is a highly nonlinear, dynamic procedure.
Electric potentials measured by EEG are generated by
nonlinear coupling interactions between neuronal popula-
tions, performing information transfer. Such activities can
best be characterized using information-theoretic measures
(Jeong 2004). Auto-mutual information measures the
mutual dependence of the EEG signal and its time-shifted
version in the same channel (Cover and Thomas 1991).
Cross-mutual information measures the mutual dependence
of a time signal and the time-shifted version of the signal in
another channel. Thereby, cross-mutual information
describes the synchrony between two different regions of
the cortex in the time domain. Both measures were com-
puted in the frequency range of 2–20 Hz.
All computations were performed using Matlab R2013b.
Values were averaged over 20-s periods.
Statistical analyses
QEEG features in relation to MMSE scores
Multiple linear regression was used to determine whether
the QEEG features could be explained by the MMSE
scores. For this study, apart from the MMSE scores, the
demographics were introduced as co-variables in linear and
quadratic terms. Thus, the x-predictors for the linear
regression were the following: MMSE, MMSE2, age, age2,
and gender.
The coefficients of determination (R2) describe how well
the model predicts the y-response in terms of the x-pre-
dictors, in proportion to the amount of variation of the
y-response. The p values for Fisher’s F tests indicate the
models’ significance. Scatter plots of the QEEG features of
each patient group were drawn for visual inspection.
Multiple linear regressions were computed with MMSE
scores as the x-predictors and the QEEG feature variables
as y-response.
Among the multitude of significant regressions, features
with opposite slopes between pairs of patients groups were
of interest in this study, because these could be clues for
supporting differential diagnoses.
Dementia group comparisons (Mann–Whitney U test)
In addition, the dementia groups were compared using
Mann–Whitney U test. This is a nonparametric test for
equality of population medians between two independent
samples. U tests were applied to determine if any of the
QEEG features showed significant differences between the
groups. Mann–Whitney U test was performed between AD
versus DLBPD, AD versus DLBPD, and bvFTD versus
DLBPD. A p value of\0.05/25 = 0.002, Bonferroni cor-
rected for 25 features, was considered significant.
Classification between dementia groups
Support vector machine (SVM) is a classification method
for data consisting of two classes. It classifies by searching
the best hyperplane that separates all data points of the two
classes. The best hyperplane is the hyperplane with the
largest maximal width of the slab parallel to the hyperplane
that has no interior data points. In this case, the QEEG
features are the data in which the SVM method searches for
a division in the data to form two classes. The SVM
classifiers classify each of the 61 patients to a dementia
group using the QEEG features. The correctness of the
classifications was then validated by the real clinical
diagnoses of the patients.
The selection of QEEG features is crucial to the per-
formance of an SVM classifier. It is important to choose
features that would distinguish between the dementia
groups. As such, the classification process consisted of
feature reduction and selection to achieve a classifier with a
minimal misclassification rate.
Feature reduction for classification
Classification of the patients was performed based on ref-
erential EEG data. A total of 25 QEEG features were
computed on all electrode or electrode channel pairs and,
when applicable, on the corresponding frequency bands.
Not all these features could be expected to contribute to the
classification of the groups. Therefore, feature reduction by
Mann–Whitney U test and principal component analysis
(PCA) was employed to alleviate the computational bur-
den, to reduce complexity of computation, and to remove
nonfactor variables. The reduction of features was done by
eliminating QEEG features that exhibited a significance
level in difference of p\ 0.05/25 in Mann–Whitney U test.
PCA transforms data into new variables called principal
components. Each of these principal components is a linear
combination of the original variables that all components
are orthogonal to each other to avoid redundancy of data.
With PCA, feature variables were selected depending on
the following criteria:
1. total variance in the principal components up to 75/80/
85/90/95%;
2. threshold for coefficients (loadings) 0.15/0.20/(0.30 for
three-way classification only).
For example, if a 90% total variance was considered
with[0.20 absolute loadings value, then only the principal
components amounting to 90% total variance were chosen.
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All variables from the chosen principal components with
loadings[|0.20| value are selected.
Ten different combinations of total variance and load-
ings absolute value were used in this study as the initial
training data for the next part of the classification process.
Included as well were the features selected through the
Mann–Whitney U test.
Classification between two dementia groups
Classification between two groups involved feature
selection and SVM classification with leave-one-out
cross validation. This classification was done for AD
versus DLBPD, AD versus bvFTD, and bvFTD versus
DLBPD.
A wrapper method type of feature selection was
employed by means of a reverse sequential feature selec-
tion. This procedure used the resulting features from the
feature reduction process as the initial training data set. In
every step, it then proceeded to combine and evaluate
different subsets of features by means of an SVM classi-
fication model with leave-one-out cross validation. It then
eliminated one variable by each step to improve the mis-
classification rate. The procedure stopped once it reached a
point where features could no longer be eliminated to
improve the misclassification rate. At this point, all the
remaining features in the training data set were considered
as the final set of training data, giving the optimum accu-
racy rating. The results of this process yielded the best
training data set for the classification of two dementia
groups.
Three-way classification
This algorithm used the classifiers from classification
between two groups. It consisted of two parts: (1) classify
whether group A or not and (2), if not, classify whether
group B or C. This resulted in two sets of feature variables
as training data for classification. For example, the first part
is a classification between AD and not AD. If it classifies as
AD, the algorithm classifies it as AD; if not, then it clas-
sifies between DLBPD and bvFTD.
Validation of classifiers
The ‘‘leave-one-out’’ method validates the classifiers
within one and the same patient group: the classifier is
trained with, for example, the first 60 patients and the 61st
patient is classified. Then, the first 59 patients and the 61st
patient are used for training and the 60th is classified, and
so on. The overall accuracy is then determined based on all
61 classification results.
Results
QEEG features in relation to MMSE scores
AD versus DLBPD: Opposite slope trends (increase with
decreasing MMSE in AD and increase with increasing
MMSE in DLBPD) were evident for features relative b1
band power Pz–O2, auto-mutual information Pz–O2, and
cross-mutual information O1–O2/Pz–O2. The electrode
sites Pz and O2 are of particular note as both were involved
in several features (opposite trends of the AD and DLBPD
groups in relation to MMSE scores for auto-mutual infor-
mation, relative band power b1, and cross-mutual infor-
mation). As an example, cross-mutual information is
shown in Fig. 1a.
AD versus bvFTD: Opposite slope trends were evident
for conditional GC Fp1/Fp2, where it decreases as the
MMSE score decreases in bvFTD patients and it increases
as the MMSE score decreases in AD patients. Trends in
opposite directions were also observed in GC O1/Fp1
(Fig. 1b).
bvFTD versus DLBPD: Opposite slope trends were
evident in partial a coherence in P7/P8 which increases as
the MMSE score decreases in DLBPD patients and
decreases as the MMSE score decreases in bvFTD patients
(Fig. 1c).
Dementia group comparisons (Mann–Whitney
U test)
The Mann–Whitney U test was performed for all QEEG
features from referential data. Considering the multiple
tests performed on the data sets, the strict criterion of
Bonferroni for statistical significance was applied
(p\ 0.002).
AD versus DLBPD: 23 of 25 features resulted in sig-
nificant differences. The features with the lowest p values
(p = 6.80e-08) were the Granger causalities at P7/P8 and
P8/P7 (see Fig. 2a). Center frequency and relative band
power a and b1 were higher in AD patients than in DLBPD
patients at all sites with significantly different results. The
opposite was true for auto-mutual information, band ratios,
relative band power h, and cross-mutual information.
AD versus bvFTD: 17 features resulted in significant
differences with GC and phase coherence b1 reaching the
lowest p value of 7.21e-8 at T7/T8. GC was significantly
higher in bvFTD patients than in AD patients while phase
coherence was significantly higher in AD patients (see
Fig. 2b). Phase coherence a and b1 was significantly
higher in AD patients than in bvFTD patients at all sites
with significantly different results. The opposite was
observed for coherence b1 and GC.
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bvFTD versus DLBPD: 12 features resulted in signifi-
cant differences with relative band power b1 at P8 and
ratio4 at P8 having the lowest p value of 2.53e-5 and 2.83e-
5, respectively. Auto-mutual information and mutual
information were higher in DLBPD patients than in bvFTD
patients at all sites with significantly different results. The
opposite was then evident for center frequency.
Classification results
Classification between two dementia groups
Classifications between AD and DLBPD, AD versus
bvFTD, and bvFTD versus DLBPD resulted in 0% mis-
classification rate (100% accuracy) based on leave-one-out
validation. With the number of patients limited to 20 or 21
patients per dementia group, the steps of accuracy are 2.5
and 2.4%. GC and ratio 4 (R4) were used as features for
training of the classifiers. The electrodes sites chosen as
features for each classifier did not necessarily follow the
results of the Mann–Whitney U Test. These results were
expected as the two did not follow the same mathematical
model. The selection of features based from the sequential
feature selection highlighted combination of features that
would give the best classifier results. Most selective elec-
trode sites for each classifier are thus:
AD versus DLBPD: GC: P8/P4; R4: O1;
AD versus bvFTD: GC: Fp1/F7, C3/P7, P3/Fp1, F3/Fp1,
T8/F8; R4: P7, Pz;
bvFTD versus DLBPD: GC: F8/T8, P4/O2, P4/C4, F8/
F7, F4/F3, C4/C3, P8/P7, C3/F7, C3/F3, C4/F4, O2/P8, P8/
P4; R4: Pz, O1.
Classification between one dementia group and the rest
Again, 100% accuracy was achieved for all three classi-
fiers. Distinguishing between AD and the rest was possible
based on just one feature (i.e., GC). The classification of
DLBPD versus the rest required the features GC and R4.
The same two features were also used for differentiating
bvFTD to achieve the same accuracy. Most selective
electrode sites or electrode pairs are:
AD versus rest: GC: P3/Fp1, P8/P7, F4/Fp2, T8/F8, P8/
P4 (Fig. 3a);
bvFTD versus rest: GC: Fp1/F3, F7/C3, F7/T7, F8/T8,
F4/C4, P4/O2, P3/C3, P3/Fp1, O1/C3, O2/C4, Fp2/Fp1,
F8/Fp2, F4/Fp2, C3/F7, T8/F8, O1/P7, O2/P4, P7/C3, P4/
C4, C3/P3, C4/P4; R4: Cz, P4 (Fig. 3b);
DLBPD versus rest: GC: C3/C4, F7/C3, P4/O2, P4/Fp2,
O1/F3, Fp2/Fp1, C4/C3, O2/O1, F8/Fp2, F4/Fp2, C3/F7,
C4/F8, O1/P7, O2/P8, P7/C3, C3/P3, P7/P3; R4: Pz, O1
(Fig. 3c).
Fig. 1 Significant regression models
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Combination of SVM classifiers
Three different combinations of SVM classifiers were
tested for maximum overall accuracy:
1. AD versus REST then bvFTD versus DLBPD;
2. DLBPD versus REST then AD versus bvFTD;
3. bvFTD versus REST then AD versus DLBPD;
The first combination (1) did the job with the least
number of features and electrode sites (Fig. 3a and d):
1. SVM 1: GC: P3/Fp1, P8/P7, F4/Fp2, T8/F8, P8/P4;
2. SVM 2: GC: F8/T8, P4/O2, P4/C4, F8/F7, F4/F3, C4/C3,
P8/P7, C3/F7, C3/F3, C4/F4, O2/P8, P8/P4; R4: Pz, O1.
Discussion and conclusions
Optimal features for differential diagnosis were found by
applying extensive signal processing: Pre-processing steps
reduced the influence of artifacts, such as eye movements,
Fig. 2 Boxplots of selected
features
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blinking, and heartbeat. An advanced method for estimat-
ing signal spectra was applied. Our study investigated 25
QEEG features characterizing frequency (spectral) prop-
erties, synchrony, and similarity of signals. For analysis,
scatter plots of these QEEG features versus MMSE scores
were generated with linear regression lines with age and
sex introduced as co-variables. Using the Mann–Whitney
U test, differences in QEEG features among the three
dementia groups were established. Finally, SVM classifiers
were trained with a selection of features to form a tool for
differentiating the dementia groups from each other.
Slowing of the frequency spectrum, which has long been
known to be a hallmark in dementia, turned out to represent
one of the two most significant features for differential
diagnosis. This is well in line with the results of the pre-
vious scientific studies (Jeong 2004). For enhancing accu-
racy, GC has been introduced for the first time and added
as an additional feature for classifier training.
Another novelty of our study is the investigation of the
relationships of QEEG features to severity of the diseases
measured in MMSE scores: In plotting QEEG features
versus the MMSE scores, auto-mutual information Pz–O2
and cross-mutual information O1–O2/Pz–O2 were found to
increase as the MMSE score decreases in AD patients and
it decreases as the MMSE decreases in DLBPD patients.
The opposite was observed for relative b1 band power Pz–
O2. Comparing AD and bvFTD, conditional GC Fp1/Fp2
increases as the MMSE score decreases in AD patients and
it decreases as MMSE score decreases in bvFTD patients.
The opposite was observed for conditional GC O1/Fp1. A
difference was observed for the feature partial coherence a
at P7/P8 between bvFTD and DLBPD patients, where there
was an increasing trend in DLBPD as the MMSE scores
decreased and the opposite for bvFTD.
The Mann–Whitney U test results showed that center
frequency, relative band power a, and relative band power
Granger causality
ratio 4
Fig. 3 Optimal features and electrode sites or pairs of electrodes for classification
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b1 at 14, 15, and 13 electrode sites, respectively, were
found to be significantly different with p\ 0.002 between
AD and DLBPD patients. GC, phase coherence a, phase
coherence b1, and coherence b1 features at 29, 14, 16, and
18 sites or pairs of sites, respectively, were significantly
different for the differentiation between AD and bvFTD.
Auto-mutual information, mutual information, and center
frequency at 5, 6, and 5 sites or pairs of sites, respectively,
for differentiating bvFTD and DLBPD were found to be
significant. This finding demonstrates AD and DLBPD to
be most dissimilar based on the number of electrode sites
results of the Mann–Whitney U test. Certain features, such
as auto-mutual information, band ratios, relative band
power h, and mutual information, were consistently higher
in DLBPD patients than in AD patients given a significant
difference between the two. The opposite was also true for
the features center frequency and relative band power a and
b1. Comparing AD and bvFTD, it was observed that phase
coherence a and b1 were higher in AD patients than in
bvFTD patients. The opposite was observed for coherence
b1 and GC. Auto-mutual information and cross-mutual
information were higher in DLBPD patients than in bvFTD
patients, whereas center frequency is higher in bvFTD
patients than in DLBPD patients.
SVM classifiers were obtained by reducing the number
of features using PCA and Mann–Whitney U test. Feature
selection was achieved using backwards sequential
selection.
Classifiers between two dementia groups and between
one dementia group and the rest performed well with 100%
accuracy based on leave-one-out validation, with GC and
the ratio of high- and low-frequency power as training
variables. The selection of the optimal electrode sites and
pairs of electrodes was different for each classifier.
Although the selection of GC electrode sites did not have
any observable pattern or common configuration, the
electrode sites for R4 were concentrated in the posterior
area (P3, P4, P7, and Pz) and at the occipital lobe (O1). The
number of features needed for the classification among AD,
DLBPD, and bvFTD with 100% accuracy was two overall.
However, it must be noted that, due to the number of
patients, accuracy ratings are in the steps of 2.5% for 20
patients (AD versus DLBPD) and 2.4% for 21 patients
(bvFTD versus DLBPD and AD versus bvFTD).
This study has indicated that QEEG features might have
the potential to support the differentiation between the
dementia groups. It has shown that the particular QEEG
features GC and the power ratio between the h and b1
bands (R4), in posterior and occipital lobes, could be of
particular benefit in differentiating the diseases.
This study only worked on 61 patients (20 AD, 20
DLBPD, and 21 bvFTD). Thus, it is necessary to conduct
further studies with more patient data per group to confirm
the results. It is also of interest to add comparisons to
normal health controls, although it would not influence the
differentiation among AD, DLBPD, and bvFTD patients
with MMSE scores less than 30.
Patients fulfilled the current clinical criteria of probable
AD, FTDbv, and DLB/PDD. The diagnoses were verified
in clinical follow-up examinations, comprising in AD and
FTDbv patients also follow-up MRI, neuropsychological
testing, and structured neuropsychiatric evaluation. CSF
analysis for tau, phosphorylated tau, and Aß1-42 could
have contributed to higher diagnostic accuracy, especially
in the differential diagnosis between FTDbv and AD, even
though there are still uncertainties about how to interprete
methodological variabilities and to overlap in the CSF
findings between these two diseases (Leuzy et al. 2016).
Amyloid PET might have added to higher diagnostic
probability in our study. However, diagnostic specificity of
amyloid PET in AD does not exceed 90% and false-posi-
tive findings or mixed pathologies may occur in FTDbv
(Clark et al. 2012; Curtis et al. 2015; Rabinovici et al.
2011; Sabri et al. 2015).
There were nine previous studies that investigated dif-
ferences in QEEG features among patients with AD,
patients with DLB or PDD, and patients with FTD. The
authors used EEG band powers, coherences, dominant
frequencies, peak a frequencies, and cortical sources. Only
three of these papers reported quantitative classification
results: Snaedal et al. (2012) also used an SVM for clas-
sification and achieved 91% accuracy in differentiating AD
from DLBPD, 93% for DLBPD-FTD and 88% for AD-
FTD (239 AD, 52 DLBPD, and 14 FTD patients). The
authors used h, a2, and b1 coherences together with peak a
frequency for classification. Andersson (Andersson et al.
2008) evaluated EEG variability in dementia with DLB and
AD. The DLB group showed higher overall coherence in
the delta band and a lower overall coherence in the alpha
band than the AD group. These features distinguished the
two patient groups with areas under the ROC curves
between 0.75 and 0.80 and 0.91 and 0.97, respectively.
Caso et al. (2012) differentiated AD from FTD patients via
12 spectral parameters in the delta, theta, alpha 1 and 2, and
beta 1, 2, and 3 frequency bands, achieving 49% sensitivity
and 85% specificity (39 FTD and 39 AD patients). Lindau
et al. (2003) differentiated AD from FTD patients as well,
achieving 93.3% classification accuracy (19 FTD and 16
AD patients). They used d and h activities together with
visuospatial ability and episodic memory.
Most studies on the differentiation among AD, DLB or
PDD, and FTD were done using SPECT or, in one case,
PET and, in another case, MR. Some of these studies were
analyzed in the recent review by Brigo et al. (2015). For
differentiating AD from DLB or PDD patients by SPECT,
sensitivities and specificities in the range of 46 up to 100%
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were found (Lobotesis et al. 2011; O´Brian et al. O’Brien
et al. 2004; Colloby et al. 2004; Hanyu et al. 2006;
McKeith et al. 2007; Colloby et al. 2008; Morgan et al.
2012; Brockhuis et al. 2015). Using PET, Gilman (Gilman
et al. 2005) reported 64.3% sensitivity and up to 69.6%
specificity for classifying DLB. Horn et al. (2007) and
Stu¨hler et al. (2011) differentiated AD and FTD patients by
SPECT with sensitivities and specificities in the range of
82–87.5%. Spehl et al. (2015) included FTD, DLB, and AD
patients. Differentiation between the groups reached areas
under the receiver-operating curve between 0.74 and 0.97.
The highest accuracy in differentiation was reached for
DLB and AD and the lowest for FTD and AD. Zhong
(Zhong et al. 2014) used 1H-proton MR spectroscopy to
differentiate DLB from AD. For 19 DLB and 21 AD
patients, the mean areas under the receiver-operating
characteristics (ROC) curves of glutamate concentrations
in the occipital lobe were 0.773 (with 66.7% sensitivity and
84.2% specificity). Franciotti et al. (2013) compared
default mode networks AD and DLB patients and found
that functional connectivity was reduced in these patients
compared to controls. Posterior cingulate cortex activity
was lower in AD than in control subjects and DLB patients.
The functional connectivity in the right hemisphere was
reduced in DLB patients in comparison with controls, but
not in AD patients.
Due to the complexity of the brain, we are not able to
specify direct interrelations among electrophysiological,
structural, and metabolic markers today. However, paral-
lels can be found: in MRI, diffusion-tensor imaging (DTI),
fMRI, SPECT, and PET studies, differences between AD
and DLBPD groups were predominantly found in parieto-
occipital and frontal and, to a lesser degree, in tem-
poroparietal electrodes/electrode combinations, in our
study in parieto-occipital locations. bvFTD is characterized
by frontal and temporal cortical and subcortical atrophy,
whereas posterior cortical areas, including the posterior
parietal and the occipital lobes, are preserved, which differs
from AD and DLBPD (Binnewijzend et al. 2014; Vemuri
et al. 2011) with sensitivities of MRI atrophy pattern
recognition ranging between 78 and 90% and specificities
of 84–98%. In our study, differences of DLBPD or AD to
bvFTD were observed largely in temporoparietal locations.
Compared to these results from SPECT, PET, and MR,
our results from QEEG seem to provide similar or even
higher accuracy, sensitivity, and specificity. This was
shown in this paper using comparable numbers of subjects.
The major difference between SPECT/PET and EEG is that
the EEG is non-invasive, much simpler to perform, widely
available, and cost-effective.
We conclude that classifiers trained with selected QEEG
features might have the potential to provide another valu-
able means of supporting the differentiation between AD,
DLBPD, and bvFTD patients and that QEEG might offer
substantial advantages over other biomarkers in terms of
practicability and accuracy. Future studies should test this
hypothesis for application not only on group level but also
for individual subjects using larger numbers of patients.
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